Iodomethyl pivalate → HCID 141559397, compound
Reaction equation
[NH2:1][C:2]1[S:3][CH:4]=[C:5](/[C:7](=[N:29]/[OH:30])/[C:8]([NH:10][CH:11]2[C:27](=[O:28])[N:13]3[C:14]([C:24]([O-:26])=[S:25])=[C:15]([CH2:18][CH:19]4[O:23][CH2:22][CH2:21][CH2:20]4)[CH2:16][S:17][C@H:12]23)=[O:9])[N:6]=1.[Na+].[C:32]([O:38][CH2:39]I)(=[O:37])[C:33]([CH3:36])([CH3:35])[CH3:34]>>[NH2:1][C:2]1[S:3][CH:4]=[C:5](/[C:7](=[N:29]/[OH:30])/[C:8]([NH:10][CH:11]2[C:27](=[O:28])[N:13]3[C:14]([C:24]([O:26][CH2:39][O:38][C:32](=[O:37])[C:33]([CH3:36])([CH3:35])[CH3:34])=[S:25])=[C:15]([CH2:18][CH:19]4[O:23][CH2:22][CH2:21][CH2:20]4)[CH2:16][S:17][C@H:12]23)=[O:9])[N:6]=1Participants
3
Procedure
Sodium 7-[(Z)-2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-tetrahydrofurfurylthio-3-cephem-4-carboxylate (50 mg) was reacted with iodomethyl pivalate (36 mg) and post-treated in the same manner as in Example 4, yielding the titled compound (15 mg; 25%) as colorless crystals.
Workup
- additionpost-treated in the same manner as in Example 4
Sources & evidence
- ORD record
- ord-9895ad6533a74c1f8c18e35df40f469d
- Source dataset
- uspto-grants-1994_07
- Patent number
- US05332731
Reaction notes
Loading…